HNB
PBYI icon

Huntington National Bank’s Puma Biotechnology PBYI Stock Holding History

Huntington National Bank’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$10K – 1645
2017
Q4 		$10K Hold
100
– – ﹤0.01% 1351
2017
Q3 		$12K Buy
+100
New +$9.3K ﹤0.01% 1326
2016
Q4 		– Sell
-179
Closed -$12K – 1489
2016
Q3 		$12K Buy
+179
New +$9.05K ﹤0.01% 1226
2016
Q2 		– Sell
-7
Closed -$2K – 1624
2016
Q1 		$2K Buy
+7
New +$316 ﹤0.01% 1656
2015
Q3 		– Sell
-8
Closed – – 1772
2015
Q2 		$0 Buy
8
+1
+14% +$181 ﹤0.01% 1809
2015
Q1 		$2K Buy
7
+2
+40% +$428 ﹤0.01% 1667
2014
Q4 		$0 Buy
+5
New +$1.11K ﹤0.01% 1755

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Huntington National Bank's PBYI Position: Q1 2018 in Review

Huntington National Bank sold out of Puma Biotechnology (PBYI) in Q1 2018, closing a stake of 100 shares — an estimated $10K sold.

Huntington National Bank first reported a position in PBYI in Q4 2014 and held it in 7 quarters. The position peaked at $12K in Q3 2017. 178 funds tracked by Wall St. Rank hold PBYI as of Q1 2018.

  • Huntington National Bank reported no remaining Puma Biotechnology position as of Q1 2018 after selling out during the quarter.
  • Huntington National Bank sold 100 Puma Biotechnology shares in Q1 2018, an estimated $10K.
  • Huntington National Bank first reported a position in Puma Biotechnology in Q4 2014 and held it in 7 quarters.
  • Huntington National Bank's Puma Biotechnology position peaked at $12K in Q3 2017.
  • 178 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2018.

Based on Huntington National Bank's 13F filing for Q1 2018, filed 30 Apr 2018.